Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform PR Newswire - Mon Mar 30, 8:00AM CDT

ABBOTT PARK, Ill. and NEW YORK , March 30, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare company, and Flatiron Health, a leading healthtech company advancing point-of-care solutions...

ABT : 102.59 (+0.70%)
Abbott hosts conference call for first-quarter earnings PR Newswire - Thu Mar 26, 8:00AM CDT

ABBOTT PARK, Ill. , March 26, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2026 financial results on Thursday, April 16, before the market opens.

ABT : 102.59 (+0.70%)
Abbott Laboratories HQ photo- by Sundry Photography via iStock
Abbott Earnings Preview: What to Expect Barchart - Wed Mar 25, 8:06AM CDT

Abbott is expected to announce its first-quarter results soon, and analysts are projecting single-digit EPS growth.

ABT : 102.59 (+0.70%)
XLV : 146.44 (+1.82%)
$SPX : 6,526.39 (+2.88%)
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening PR Newswire - Tue Mar 24, 7:00AM CDT

ABBOTT PARK, Ill. , March 24, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a new campaign encouraging people to stop avoiding awkward conversations about colorectal cancer. The company...

ABT : 102.59 (+0.70%)
Abbott completes acquisition of Exact Sciences PR Newswire - Mon Mar 23, 7:50AM CDT

ABBOTT PARK, Ill. , March 23, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening...

ABT : 102.59 (+0.70%)
Abbott acquisition of Exact Sciences set to close on March 23, 2026 PR Newswire - Fri Mar 20, 8:00AM CDT

ABBOTT PARK, Ill. , March 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026. The announcement follows...

ABT : 102.59 (+0.70%)
A gold crown with sparkling dust by tomertu via Shutterstock
3 High Dividend Growth Kings for Generations of Income That Are Still Rated ‘Buy’ Barchart - Wed Mar 18, 8:35AM CDT

These 3 Dividend Kings combine steady businesses, rising dividends, and solid upside potential for long-term income investors.

ABT : 102.59 (+0.70%)
LOW : 236.28 (+1.59%)
RPM : 99.43 (+1.40%)
A gold crown with sparkling dust by tomertu via Shutterstock
This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip? Barchart - Mon Mar 16, 6:30PM CDT

This Dividend King is suddenly on sale. Should you buy the dip?

ABT : 102.59 (+0.70%)
$SPX : 6,526.39 (+2.88%)
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management PR Newswire - Thu Mar 12, 7:00AM CDT

ABBOTT PARK, Ill. , March 12, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using...

ABT : 102.59 (+0.70%)
ABT
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks StockStory - Wed Mar 11, 10:31PM CDT

Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

ABT : 102.59 (+0.70%)

Barchart Exclusives

Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock? Barchart - 28 minutes ago
Apellis Pharma stock more than doubled as Biogen announced a $5.6 billion acquisition. But for investors looking to jump into APLS shares now, the ship has already sailed. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.